Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients

Objective: The aim of this study was to investigate factors associated with thrombosis that may contribute to recurrent pregnancy loss (habitual abortion), specifically differences in serum levels of platelet-activating factor and thrombin-activatable fibrinolysis inhibitor (carboxypeptidase B2) bet...

Full description

Bibliographic Details
Main Authors: Ayla Eser, Ilknur Inegol Gumus, Husamettin Erdamar, Ikbal Kaygusuz, Melahat Yildirim, Betul Usluogullari, Muzeyyen Duran Erdolu, Serap Aynur Simavli, Ramazan Yigitoglu, Nilgun Ozturk Turhan
Format: Article
Language:English
Published: Elsevier 2016-02-01
Series:Taiwanese Journal of Obstetrics & Gynecology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1028455915002958
id doaj-3e76acf961ef41e0b9cc3c19c5f93deb
record_format Article
spelling doaj-3e76acf961ef41e0b9cc3c19c5f93deb2020-11-24T22:22:17ZengElsevierTaiwanese Journal of Obstetrics & Gynecology1028-45592016-02-01551606310.1016/j.tjog.2015.06.013Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patientsAyla Eser0Ilknur Inegol Gumus1Husamettin Erdamar2Ikbal Kaygusuz3Melahat Yildirim4Betul Usluogullari5Muzeyyen Duran Erdolu6Serap Aynur Simavli7Ramazan Yigitoglu8Nilgun Ozturk Turhan9Department of Obstetrics and Gynecology, Turgut Ozal University Medical School, Ankara, TurkeyDepartment of Obstetrics and Gynecology, Turgut Ozal University Medical School, Ankara, TurkeyDepartment of Biochemistry, Turgut Ozal University Medical School, Ankara, TurkeyDepartment of Obstetrics and Gynecology, Turgut Ozal University Medical School, Ankara, TurkeyDepartment of Obstetrics and Gynecology, Ataturk Education and Research Hospital, Ankara, TurkeyDepartment of Obstetrics and Gynecology, Cengiz Gokcek Hospital, Gaziantep, TurkeyDepartment of Obstetrics and Gynecology, Sevket Yilmaz Education and Research Hospital, Bursa, TurkeyDepartment of Obstetrics and Gynecology, Pamukkale University Medical School, Denizli, TurkeyDepartment of Biochemistry, Turgut Ozal University Medical School, Ankara, TurkeyDepartment of Obstetrics and Gynecology, Sitki Kocman University Medical School, Mugla, TurkeyObjective: The aim of this study was to investigate factors associated with thrombosis that may contribute to recurrent pregnancy loss (habitual abortion), specifically differences in serum levels of platelet-activating factor and thrombin-activatable fibrinolysis inhibitor (carboxypeptidase B2) between women with a history of recurrent miscarriage and those with no recurrent miscarriage history. Materials and methods: A case-controlled, prospective study design was adopted to compare women with a history of two or more first-trimester miscarriages (n = 42) with those with no history of recurrent miscarriage (n = 36). Participants were recruited from the Department of Obstetrics and Gynecology of Turgut Ozal University Hospital. Platelet-activating factor and thrombin-activatable fibrinolysis inhibitor levels in serum samples were measured by an enzyme-linked immunosorbent assay. Results: Platelet-activating factor levels were significantly (p = 0.018) higher in the recurrent miscarriage group. There was no difference in levels of thrombin-activatable fibrinolysis inhibitor expression between the groups. Conclusion: Platelet-activating factor is significantly higher in serum of patients with a history of recurrent miscarriage than in those without such a history, with potential implications for placental function and fetal growth, which could be relevant to miscarriage recurrence. Larger studies are indicated to further examine these findings.http://www.sciencedirect.com/science/article/pii/S1028455915002958abortionhabitualcarboxypeptidase B2platelet activating factorpregnancy
collection DOAJ
language English
format Article
sources DOAJ
author Ayla Eser
Ilknur Inegol Gumus
Husamettin Erdamar
Ikbal Kaygusuz
Melahat Yildirim
Betul Usluogullari
Muzeyyen Duran Erdolu
Serap Aynur Simavli
Ramazan Yigitoglu
Nilgun Ozturk Turhan
spellingShingle Ayla Eser
Ilknur Inegol Gumus
Husamettin Erdamar
Ikbal Kaygusuz
Melahat Yildirim
Betul Usluogullari
Muzeyyen Duran Erdolu
Serap Aynur Simavli
Ramazan Yigitoglu
Nilgun Ozturk Turhan
Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients
Taiwanese Journal of Obstetrics & Gynecology
abortion
habitual
carboxypeptidase B2
platelet activating factor
pregnancy
author_facet Ayla Eser
Ilknur Inegol Gumus
Husamettin Erdamar
Ikbal Kaygusuz
Melahat Yildirim
Betul Usluogullari
Muzeyyen Duran Erdolu
Serap Aynur Simavli
Ramazan Yigitoglu
Nilgun Ozturk Turhan
author_sort Ayla Eser
title Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients
title_short Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients
title_full Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients
title_fullStr Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients
title_full_unstemmed Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients
title_sort levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients
publisher Elsevier
series Taiwanese Journal of Obstetrics & Gynecology
issn 1028-4559
publishDate 2016-02-01
description Objective: The aim of this study was to investigate factors associated with thrombosis that may contribute to recurrent pregnancy loss (habitual abortion), specifically differences in serum levels of platelet-activating factor and thrombin-activatable fibrinolysis inhibitor (carboxypeptidase B2) between women with a history of recurrent miscarriage and those with no recurrent miscarriage history. Materials and methods: A case-controlled, prospective study design was adopted to compare women with a history of two or more first-trimester miscarriages (n = 42) with those with no history of recurrent miscarriage (n = 36). Participants were recruited from the Department of Obstetrics and Gynecology of Turgut Ozal University Hospital. Platelet-activating factor and thrombin-activatable fibrinolysis inhibitor levels in serum samples were measured by an enzyme-linked immunosorbent assay. Results: Platelet-activating factor levels were significantly (p = 0.018) higher in the recurrent miscarriage group. There was no difference in levels of thrombin-activatable fibrinolysis inhibitor expression between the groups. Conclusion: Platelet-activating factor is significantly higher in serum of patients with a history of recurrent miscarriage than in those without such a history, with potential implications for placental function and fetal growth, which could be relevant to miscarriage recurrence. Larger studies are indicated to further examine these findings.
topic abortion
habitual
carboxypeptidase B2
platelet activating factor
pregnancy
url http://www.sciencedirect.com/science/article/pii/S1028455915002958
work_keys_str_mv AT aylaeser levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients
AT ilknurinegolgumus levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients
AT husamettinerdamar levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients
AT ikbalkaygusuz levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients
AT melahatyildirim levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients
AT betulusluogullari levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients
AT muzeyyenduranerdolu levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients
AT serapaynursimavli levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients
AT ramazanyigitoglu levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients
AT nilgunozturkturhan levelsofthrombinactivatablefibrinolysisinhibitorandplateletactivatingfactorinrecurrentpregnancylosspatients
_version_ 1725769007551741952